Bariatric surgery, vitamin C, and kidney stones

Cleveland Clinic Journal of Medicine

Volumn 77, Issue 12, 2010, Pages 844-844

  Weiss, Daniel ^a  

^a Nutrition Group Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; CALCIUM OXALATE;

BARIATRIC SURGERY; CHEMICALLY INDUCED DISORDER; CHEMISTRY; HUMAN; LETTER; METABOLISM; NEPHROLITHIASIS; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTOPERATIVE COMPLICATION; RISK FACTOR;

ASCORBIC ACID; BARIATRIC SURGERY; CALCIUM OXALATE; DIABETES MELLITUS, TYPE 2; HUMANS; KIDNEY CALCULI; POSTOPERATIVE COMPLICATIONS; RISK FACTORS;

EID: 78650352826     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.77c.12003     Document Type: Letter

References (6)

1. Kashyap SR, Gatmaitan P, Brethauer S, Schauer P. Bariatric surgery for type 2 diabetes: weighing the impact for obese patients. Cleve Clin J Med 2010; 77:468-476.
2. Lieske JC, Kumar R, Collazo-Clavell ML. Nephrolithiasis after bariatric surgery for obesity. Semin Nephrol 2008; 28:163-173.
3. Asplin JR, Coe FL. Hyperoxaluria in kidney stone formers treated with modern bariatric surgery. J Urol 2007; 177:565-569.
4. Massey LK, Liebman M, Kynast-Gales SA. Ascorbate increases human oxaluria and kidney stone risk. J Nutr 2005; 135:1673-1677.
5. Rhode BM, Shustik C, Christou NV, MacLean LD. Iron absorption and therapy after gastric bypass. Obes Surg 1999; 9:17-21.
6. Hunt JR, Gallagher SK, Johnson LK. Effect of ascorbic acid on apparent iron absorption by women with low iron stores. Am J Clin Nutr 1994; 59:1381-1385.